Indian J Pharm Close
 

Figure 2: (a) PFS estimates according to smoking status. (b) PFS estimates according to EGFR mutation status. (c) PFS estimates according to EGFR mutation - positive patients. (d) PFS estimates according to EGFR mutation - negative patients. PFS, progression - free survival; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor

Figure 2: (a) PFS estimates according to smoking status. (b) PFS estimates according to EGFR mutation status. (c) PFS estimates according to EGFR mutation - positive patients. (d) PFS estimates according to EGFR mutation - negative patients. PFS, progression - free survival; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor